
The SCOTUS Tariff Decision Fallout 2/23/26
Halftime Report
00:00
Obesity Drug Trial Moves Healthcare Stocks
Panel reacts to Novo Nordisk results favoring Eli Lilly and implications for healthcare sector positioning, including Lilly ownership.
Play episode from 24:08
Transcript


